Search research articles
Contact Us
Filters
Showing results (51-60 of 69) with videos related to
Page
of 7
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 19, 1997
Lung cancer practice guidelines: lessons learned and issues addressed by the Ontario Lung Cancer Disease Site Group
W K Evans, T Newman, I Graham, et al.
Cancer
|
August 16, 2001
Phase II study of pemetrexed disodium, a multitargeted antifolate, and cisplatin as first-line therapy in patients with advanced nonsmall cell lung carcinoma: a study of the National Cancer Institute of Canada Clinical Trials Group
F A Shepherd, J Dancey, A Arnold, et al.
Seminars in Oncology
|
February 7, 2003
Pemetrexed safety and dosing strategy
Clet Niyikiza, Axel-R Hanauske, James J Rusthoven, et al.
Journal of the National Cancer Institute
|
December 4, 1991
Two phase I studies of carboplatin dose escalation in chemotherapy-naive ovarian cancer patients supported with granulocyte-macrophage colony-stimulating factor
J Rusthoven, L Levin, E Eisenhauer, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
|
November 15, 1987
Re-evaluating the cost of outpatient cancer chemotherapy
H B Wodinsky, C DeAngelis, J J Rusthoven, et al.
Journal of the National Cancer Institute
|
August 21, 1991
Superiority of granisetron to dexamethasone plus prochlorperazine in the prevention of chemotherapy-induced emesis
D Warr, A Willan, S Fine, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
September 1, 1995
Dexamethasone improves the efficacy of granisetron in the first 24 h following high-dose cisplatin chemotherapy
J Latreille, D Stewart, F Laberge, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale
|
October 1, 1988
Failure of methylprednisolone acetate to prolong the antinauseant effect of intravenous methylprednisolone sodium succinate in patients receiving chemotherapy
D Osoba, C Erlichman, A R Willan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 1, 1991
A randomized, double-blinded study comparing six doses of batanopride (BMY-25801) with methylprednisolone in patients receiving moderately emetogenic chemotherapy
J Rusthoven, J Pater, L Kaizer, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
January 1, 1989
Carcinoembryonic antigen, arginine vasopressin and calcitonin as markers of early small-cell lung cancer relapse
H Biran, R Feld, U Sagman, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 69) with videos related to
Sort By:
Page
of 7
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 19, 1997
Lung cancer practice guidelines: lessons learned and issues addressed by the Ontario Lung Cancer Disease Site Group
W K Evans, T Newman, I Graham, et al.
Cancer
|
August 16, 2001
Phase II study of pemetrexed disodium, a multitargeted antifolate, and cisplatin as first-line therapy in patients with advanced nonsmall cell lung carcinoma: a study of the National Cancer Institute of Canada Clinical Trials Group
F A Shepherd, J Dancey, A Arnold, et al.
Seminars in Oncology
|
February 7, 2003
Pemetrexed safety and dosing strategy
Clet Niyikiza, Axel-R Hanauske, James J Rusthoven, et al.
Journal of the National Cancer Institute
|
December 4, 1991
Two phase I studies of carboplatin dose escalation in chemotherapy-naive ovarian cancer patients supported with granulocyte-macrophage colony-stimulating factor
J Rusthoven, L Levin, E Eisenhauer, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
|
November 15, 1987
Re-evaluating the cost of outpatient cancer chemotherapy
H B Wodinsky, C DeAngelis, J J Rusthoven, et al.
Journal of the National Cancer Institute
|
August 21, 1991
Superiority of granisetron to dexamethasone plus prochlorperazine in the prevention of chemotherapy-induced emesis
D Warr, A Willan, S Fine, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
September 1, 1995
Dexamethasone improves the efficacy of granisetron in the first 24 h following high-dose cisplatin chemotherapy
J Latreille, D Stewart, F Laberge, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale
|
October 1, 1988
Failure of methylprednisolone acetate to prolong the antinauseant effect of intravenous methylprednisolone sodium succinate in patients receiving chemotherapy
D Osoba, C Erlichman, A R Willan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 1, 1991
A randomized, double-blinded study comparing six doses of batanopride (BMY-25801) with methylprednisolone in patients receiving moderately emetogenic chemotherapy
J Rusthoven, J Pater, L Kaizer, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
January 1, 1989
Carcinoembryonic antigen, arginine vasopressin and calcitonin as markers of early small-cell lung cancer relapse
H Biran, R Feld, U Sagman, et al.
Page
of 7